Lastly, intraperitoneal administration of recombinant extracellular SEMA6A in mouse inhibited both bFGF/VEGF and tumour cell line-induced neovascularisation (Dhanabal et al, 2005). The gene discussed is VEGFA; the disease is neoplasm.